Thomas Rudin

Thomas Rudin currently serves as CEO of Bethesda Spital AG since May 2010 and holds multiple leadership roles, including Verwaltungsratspräsident at Palliativzentrum Hildegard and Klinik Sonnenhalde AG since April 2024 and May 2013, respectively. In addition, Thomas Rudin is a Stiftungsrat at Gritt Seniorenzentrum and has been involved with Onko - Praxis Bethesda AG and Spitex Regio Liestal as Verwaltungsratspräsident and Vize-Präsident, respectively. Prior roles include Leitung Finanzen und Verwaltung at Spital Zofingen AG and leadership positions at Novartis and Universitäre Psychiatrische Kliniken UPK Basel. Education includes a program at Rochester-Bern Executive Programs completed in August 2022.